In addition to discussing potential cardiovascular worries associated with Clarus Therapeutics Inc.'s proposed oral testosterone replacement therapy Jatenzo, a US FDA advisory committee also will consider whether the type of tube used to collect samples for dose titration will affect the safe use of the product.
Jatenzo (testosterone undecanoate) is vying for approval as an oral testosterone therapy. The Bone, Reproductive and Urologic Drugs Advisory Committee...





